NCT02692794

Brief Summary

Deliberate hypotension, reverse Trendelenburg position, and hyperventilation are techniques utilized during functional endoscopic sinus surgery to attempt to reduce surgical bleeding. These methods reduce blood flow to the head and neck area and assist in reducing bleeding during surgery but they may predispose patients to cerebral ischemia. Large scale studies necessary to conduct adequate statistical analysis regarding the effect of cerebral oximetry on otolaryngology surgery has not been extensively studied. This study seek to address the question of whether cerebral oximetry in the FESS population can help evaluate major and minor post operative morbidity, as well as the quality of recovery from surgery. Cerebral oximeters are small, noninvasive stickers applied to the forehead of participants and give the examiners data regarding the level of oxygen saturation around the brain during the course of surgery. During the course of such procedures, where blood flow to the head and neck area is intentionally decreased to assist in reducing bleeding during surgery, the levels of oxygen saturation around the brain may pose as a predictor or major and minor post operative morbidity, as well as the quality of recovery from surgery. Outcome measures will include major post operative complications, such as neurological and cardiac complications, and minor post operative morbidity, such as length of post anesthesia care unit (PACU) length of stay, nausea, and vomiting. Quality of recovery will also be assessed using a survey conducted in the PACU and again at the first post operative visit approximately one week after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2015

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 23, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 26, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2016

Completed
Last Updated

August 10, 2017

Status Verified

August 1, 2017

Enrollment Period

9 months

First QC Date

February 23, 2016

Last Update Submit

August 8, 2017

Conditions

Keywords

sinusitisoximetryparanasal sinus diseases

Outcome Measures

Primary Outcomes (2)

  • Post-operative Quality of Recovery Scale

    Post-operative Quality of Recovery Scale to assess cognitive delay in patients undergoing sinus surgery

    Day 1- 1 hour post-operatively

  • Post-operative Quality of Recovery Scale

    Post-operative Quality of Recovery Scale to assess cognitive delay in patients undergoing sinus surgery

    Day 2

Secondary Outcomes (1)

  • Incidence of nausea/vomiting

    Day 1 - 1 hour post-operatively

Other Outcomes (1)

  • Incidence of pain experience

    Day 1 - 1 hour post-operatively

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing primary or revision endoscopic sinus surgery for chronic rhinosinusitis

You may qualify if:

  • \- patients undergoing elective head and neck surgery at Mount Sinai Hospital in which 1) the patient will be intubated and mechanically ventilated, with 2) head of bed elevated, and in which 3) an anesthesiologist could consider deliberate hypotension as part of their management

You may not qualify if:

  • patients under 18 years old
  • patients who are currently prisoners
  • patients who do not appear to have capacity to consent to the study
  • patients who cannot provide informed consent in English
  • pregnant women
  • patients who decline to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Icahn School of Medicine

New York, New York, 10029, United States

Location

Biospecimen

Retention: NONE RETAINED

Specify all types of biospecimens to be retained (e.g., whole blood, serum, white cells, urine, tissue)

MeSH Terms

Conditions

SinusitisParanasal Sinus Diseases

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsNose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Satish Govindaraj, MD

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2016

First Posted

February 26, 2016

Study Start

October 1, 2015

Primary Completion

June 20, 2016

Study Completion

June 20, 2016

Last Updated

August 10, 2017

Record last verified: 2017-08

Data Sharing

IPD Sharing
Will not share

Locations